Latest Insider Transactions at Bio Cardia, Inc. (BCDA)
This section provides a real-time view of insider transactions for Bio Cardia, Inc. (BCDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioCardia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioCardia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2024
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
108,108
+16.29%
|
$0
$0.46 P/Share
|
|
Jan 19
2024
|
Phillip Md Et Al Frost > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
129,802
-6.41%
|
$0
$0.43 P/Share
|
|
Aug 17
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+0.89%
|
$0
$0.87 P/Share
|
|
Aug 14
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+1.0%
|
$0
$0.88 P/Share
|
|
Jun 23
2023
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,280
+3.06%
|
$8,560
$2.34 P/Share
|
|
Jun 23
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,421
+1.44%
|
$12,842
$2.34 P/Share
|
|
Jun 23
2023
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+19.34%
|
$128,424
$2.34 P/Share
|
|
Jun 23
2023
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+23.3%
|
$128,424
$2.34 P/Share
|
|
Jun 23
2023
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+6.7%
|
$128,424
$2.34 P/Share
|
|
May 31
2023
|
Edward M Gillis Senior Vice President, Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
15,512
-24.1%
|
$15,512
$1.77 P/Share
|
|
May 31
2023
|
Peter Altman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,821
-7.85%
|
$36,821
$1.77 P/Share
|
|
May 31
2023
|
David Mc Clung Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,676
-13.59%
|
$20,676
$1.77 P/Share
|
|
May 26
2023
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
6,200
+1.3%
|
$6,200
$1.6 P/Share
|
|
May 18
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109,324
+19.1%
|
$109,324
$1.7 P/Share
|
|
May 18
2023
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,389
+28.75%
|
$61,389
$1.7 P/Share
|
|
May 18
2023
|
Edward M Gillis Senior Vice President, Devices |
BUY
Grant, award, or other acquisition
|
Direct |
40,490
+50.0%
|
$40,490
$1.7 P/Share
|
|
Dec 16
2022
|
Phillip Md Et Al Frost > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
595,238
+22.71%
|
$595,238
$1.68 P/Share
|
|
Dec 16
2022
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,928
+9.26%
|
$8,928
$1.68 P/Share
|
|
Dec 16
2022
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
178,571
+16.74%
|
$178,571
$1.68 P/Share
|
|
Dec 16
2022
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,880
+4.1%
|
$14,880
$1.68 P/Share
|
|
Dec 16
2022
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Indirect |
148,809
+33.78%
|
$148,809
$1.68 P/Share
|
|
Dec 16
2022
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
148,809
+15.19%
|
$148,809
$1.68 P/Share
|
|
Oct 10
2022
|
David Mc Clung Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+2.48%
|
$4,000
$2.07 P/Share
|
|
Sep 23
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
1,400
+0.42%
|
$1,400
$1.87 P/Share
|
|
Sep 22
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
3,100
+0.94%
|
$3,100
$1.81 P/Share
|
|
Sep 21
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,750
+0.84%
|
$2,750
$1.92 P/Share
|
|
Jun 10
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
4,500
+1.38%
|
$4,500
$1.46 P/Share
|
|
May 13
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,698
+0.77%
|
$2,698
$1.38 P/Share
|
|
May 12
2022
|
David Mc Clung Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,632
-21.24%
|
$20,632
$1.32 P/Share
|
|
May 12
2022
|
Edward M Gillis Senior Vice President, Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
12,358
-34.1%
|
$12,358
$1.32 P/Share
|
|
May 12
2022
|
Peter Altman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,446
-9.03%
|
$31,446
$1.32 P/Share
|
|
May 12
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
11,302
+3.17%
|
$11,302
$1.2 P/Share
|
|
May 11
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.3%
|
$1,000
$1.3 P/Share
|
|
Apr 29
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,700
+0.8%
|
$2,700
$1.61 P/Share
|
|
Apr 28
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,300
+0.69%
|
$2,300
$1.59 P/Share
|
|
Apr 18
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
13,500
+3.95%
|
$13,500
$1.39 P/Share
|
|
Apr 14
2022
|
Edward M Gillis Senior Vice President, Devices |
BUY
Grant, award, or other acquisition
|
Direct |
30,155
+45.42%
|
-
|
|
Apr 14
2022
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,345
+34.13%
|
-
|
|
Apr 14
2022
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
76,734
+19.61%
|
-
|
|
Jan 11
2022
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
100
+0.03%
|
$100
$1.87 P/Share
|
|
Nov 18
2021
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+2.06%
|
$10,000
$2.2 P/Share
|
|
Aug 17
2021
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+1.48%
|
$7,000
$2.94 P/Share
|
|
Jun 10
2021
|
Edward M Gillis Senior Vice President, Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
9,953
-62.07%
|
$39,812
$4.35 P/Share
|
|
Jun 10
2021
|
David Mc Clung Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,274
-13.45%
|
$29,096
$4.35 P/Share
|
|
Jun 10
2021
|
Peter Altman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,572
-4.8%
|
$46,288
$4.35 P/Share
|
|
Apr 21
2021
|
Edward M Gillis Senior Vice President, Devices |
SELL
Grant, award, or other acquisition
|
Direct |
9,953
-50.0%
|
-
|
|
Apr 21
2021
|
Peter Altman President and CEO |
SELL
Grant, award, or other acquisition
|
Direct |
33,581
-12.23%
|
-
|
|
Apr 21
2021
|
David Mc Clung Chief Financial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
21,370
-28.32%
|
-
|
|
Mar 31
2021
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,304
+1.12%
|
-
|
|
Mar 31
2021
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,520
+0.37%
|
-
|